SUBMIT BOOK PROPOSAL
Online Store
benthambooks logo

Site Breadcrumb

Frontiers in Anti-Cancer Drug Discovery
View Sample

Editors: Atta-ur-Rahman, FRS , M. Iqbal Choudhary

Frontiers in Anti-Cancer Drug Discovery

Volume 9
eBook: US $99 Special Offer (PDF + Printed Copy): US $168
Printed Copy: US $119
Library License: US $396
ISSN: 2451-8395 (Print)
ISSN: 1879-6656 (Online)
ISBN: 978-1-68108-702-3 (Print)
ISBN: 978-1-68108-701-6 (Online)
Year of Publication: 2018
DOI: 10.2174/97816810870161180901
Rate This Book

Introduction

Frontiers in Anti-Cancer Drug Discovery is a book series devoted to publishing the latest advances in anti-cancer drug design and discovery. In each volume, eminent scientists contribute reviews relevant to all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The book series should prove to be of interest to all pharmaceutical scientists involved in research in anti-cancer drug design and discovery. The book series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

The ninth volume of the series features chapters covering the following topics: - New research on the therapeutic intervention of cancer and cancer drug delivery - Dabrafenib usage in melanoma therapy - Targeting autophagy in cancer therapy - Pro-apoptotic and anti-telomerase activity of naturally occurring compounds - CDK inhibitors - Oral nanostructure drug delivery for anti-cancer treatment

Indexed in: EMBASE


eBook: US $99 Special Offer: US $168 Printed Copy: US $119 Library License: US $396

Contributors

Editor(s):
Prof. Atta-ur-Rahman, FRS
University of Cambridge
Kings College
Cambridge
UK


Prof. M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
University of Karachi
Karachi-75270
Pakistan



Contributor(s):
Abrar E. Srouji
Department of Pharmaceutics, RAK College of Pharmaceutical Sciences
RAK Medical & Health Sciences University
UAE


Aditi Gangopadhyay
University of Calcutta
Kolkata, West Bengal
India
/
Jhargram Raj College
Paschim Medinipur, West Bengal
India


Alyazya Mohammed
Department of Pharmaceutics, RAK College of Pharmaceutical Sciences
RAK Medical & Health Sciences University
UAE


Ana Podolski-Renić
Institute for Biological Research “Siniša Stanković”
University of Belgrade
Belgrade
Serbia


Aparna Gangopadhyay
University of Calcutta
Kolkata, West Bengal
India
/
Chittaranjan National Cancer Institute
Kolkata, West Bengal
India


Claudio Daniel Gonzalez
University Institute CEMIC (Center for Medical Education and Clinical Research)
Buenos Aires
Argentina


Ekta Khattar
Department of Biological Sciences, Sunandan Divatia School of Science
SVKM's NMIMS (Deemed-to-be University)
Vile Parle (West), Mumbai
India


Hemant K.S Yadav
Department of Pharmaceutics, RAK College of Pharmaceutical Sciences
RAK Medical & Health Sciences University
UAE


Jelena Dinić
Institute for Biological Research “Siniša Stanković”
University of Belgrade
Belgrade
Serbia


Mahendar Porika
Department of Biotechnology
Kakatiya University
Warangal, Telangana
India


Manar Dibi
Department of Pharmaceutics, RAK College of Pharmaceutical Sciences
RAK Medical & Health Sciences University
UAE


Maria Ines Vaccaro
Institute of Biochemistry and Molecular Medicine (CONICET), School of Pharmacy and Biochemistry
University of Buenos Aires
Buenos Aires
Argentina


Meredith McKean
Department of Melanoma Medical Oncology
MD Anderson Cancer Center
Houston, TX
USA


Milica Pešić
Institute for Biological Research “Siniša Stanković”
University of Belgrade
Belgrade
Serbia


Nazneen Firdous
Department of Obstetrics and Gynaecology
Uzhgorod National University
Uzhgorod
Ukraine


Nhi Nguyen
School of Biological Sciences (SBS)
Nanyang Technological University (NTU)
60 Nanyang Drive
Singapore


Radhika Tippani
Department of Biotechnology
Kakatiya University
Warangal, Telangana
India


Rodabe N. Amaria
Department of Melanoma Medical Oncology
MD Anderson Cancer Center
Houston, TX
USA


Stina George Fernandes
Department of Biological Sciences, Sunandan Divatia School of Science
SVKM's NMIMS (Deemed-to-be University)
Vile Parle (West), Mumbai
India


Tijana Stanković
Institute for Biological Research “Siniša Stanković”
University of Belgrade
Belgrade
Serbia


Yinghui Li
School of Biological Sciences (SBS)
Nanyang Technological University (NTU)
60 Nanyang Drive
Singapore